Skip to main content

Abpro Holdings, Inc.

ABPO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001893219

No open-market purchases or sales by Abpro Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesABPWW

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Abpro Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Abpro Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Abpro Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Lee Soo YoungDirector–Aug 7, 20250
Suk Jin Wook (Miles)CEO and Chairman718,512Aug 4, 20250
Eisenberg Anthony D.Director–Jul 29, 20250
Chan IanChief Executive Officer987,400IndirectNov 25, 20240
Markelewicz Robert J. Jr.Chief Medical Officer–Nov 15, 20240
Ahmad ShahraabChairman and CEO7,199,999IndirectNov 8, 20230
Atlantic Coastal Acquisition Management II LLC10% Owner7,199,999IndirectNov 8, 20230
Kahlon IqbaljitDirector0Nov 8, 20230
Schiano DominickDirector50,000Apr 19, 20230
Lord JoannaDirector50,000Apr 19, 20230
Dove BryanDirector50,000Apr 19, 20230
Stanwood DarrenDirector50,000Apr 19, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 25, 2025 (view filing)4:58 PM ETApr 23-242 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+34.0K$0.3268+$11.1K+37.0%125.9K after2 lots
May 1, 2025 (view filing)4:21 PM ETApr 292 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+4.33K$0.25+$1.08K+3.4%130.3K after
May 19, 2025 (view filing)8:37 PM ETMay 19Same daySuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+16.2K$0.26+$4.21K+12.4%146.5K after
Aug 4, 2025 (view filing)5:22 PM ETJul 314 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+72.0K$0.28+$20.2K+11.1%718.5K after